265 related articles for article (PubMed ID: 4064041)
21. [Clinical significance of CEA levels in lung cancer].
Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
[TBL] [Abstract][Full Text] [Related]
22. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
24. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
25. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
Ciaccio B; Caponi A; Cappetti P; Fanciullacci A; Bartoli P; Berti P
Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962
[TBL] [Abstract][Full Text] [Related]
26. Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content.
Pagé M; Dalifard I; Bertrand G; Bocquillon PG; Daver A
Anticancer Res; 1986; 6(5):893-6. PubMed ID: 3541780
[TBL] [Abstract][Full Text] [Related]
27. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
[No Abstract] [Full Text] [Related]
28. Immunohistochemical study of lysozyme, alpha 1-anti-chymotrypsin, tissue polypeptide antigen, keratin and carcinoembryonic antigen in effusion sediments.
Permanetter W; Wiesinger H
Acta Cytol; 1987; 31(2):104-12. PubMed ID: 2435101
[TBL] [Abstract][Full Text] [Related]
29. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
30. [Exposure to asbestos and levels of selected tumor biomarkers].
Krajewska B; Lutz W; Piłacik B
Med Pr; 1996; 47(2):89-96. PubMed ID: 8657007
[TBL] [Abstract][Full Text] [Related]
31. [Portal blood level of carcinoembryonic antigen (CEA) in colorectal cancer: correlation between tumor CEA content and immunohistochemical staining].
Shimoyama T; Fukuda Y; Kusano H; Shimizu T; Takahira R; Itoh S; Watabe S; Miyashita K; Ishikawa H; Nakagoe T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2245-50. PubMed ID: 2457355
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
33. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A
Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
[TBL] [Abstract][Full Text] [Related]
35. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer].
Kanauchi M; Sawai F; Hirayama T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1985 Sep; 31(11):1367-71. PubMed ID: 2999464
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
40. [Carcinoembryonic antigen in intestinal lavage fluids and the tissue of colorectal tumors].
Beaudonnet A; Revenant MC; Guillaud M; Thomas D; Bérard P; Evreux M; Pichot J; Goudable J
Pathol Biol (Paris); 1985 Jan; 33(1):9-14. PubMed ID: 3883295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
